July 10, 2020 / 7:38 PM / 25 days ago

BRIEF-Davidson Kempner European Partners In Letter To Qiagen Says Believe Offer Of €39/Share From Thermo Fisher Scientific Is "Inadequate"

July 10 (Reuters) - Davidson Kempner European Partners:

* DAVIDSON KEMPNER EUROPEAN PARTNERS SENDS LETTER TO QIAGEN NV

* DAVIDSON KEMPNER EUROPEAN PARTNERS IN LETTER TO QIAGEN SAYS BELIEVE OFFER OF €39/SHARE FROM THERMO FISHER SCIENTIFIC IS “INADEQUATE”

* DAVIDSON KEMPNER EUROPEAN PARTNERS IN LETTER TO QIAGEN SAYS QIAGEN BOARD SHOULD ISSUE AN ADVERSE RECOMMENDATION CHANGE

* DAVIDSON KEMPNER EUROPEAN PARTNERS IN LETTER TO QIAGEN SAYS BELIEVE THE STANDALONE FAIR VALUE OF QIAGEN TO BE AROUND €50/SHARE

* DAVIDSON KEMPNER EUROPEAN PARTNERS IN LETTER TO QIAGEN SAYS WILL NOT BE TENDERING SHARES INTO THE OFFER

* DAVIDSON KEMPNER EUROPEAN - URGE QIAGEN TO EXERCISE CAUTION WHEN CONSIDERING SUPPORT FOR REQUEST TO LOWER ACCEPTANCE CONDITION FROM THERMO FISHER Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below